Case Report: An Atypical Form of Familial Partial Lipodystrophy Type 2 Due to Mutation in the Rod Domain of Lamin A/C

Front Endocrinol (Lausanne). 2021 Apr 19:12:675096. doi: 10.3389/fendo.2021.675096. eCollection 2021.

Abstract

Purpose: Familial partial lipodystrophy type 2 (FPLD2) patients generally develop a wide variety of severe metabolic complications. However, they are not usually affected by primary cardiomyopathy and conduction system disturbances, although a few cases of FPLD2 and cardiomyopathy have been reported in the literature. These were all due to amino-terminal heterozygous lamin A/C mutations, which are considered as new forms of overlapping syndromes.

Methods and results: Here we report the identification of a female patient with FPLD2 due to a heterozygous missense variant c.604G>A in the exon 3 of the LMNA gene, leading to amino acid substitution (p.Glu202Lys) in the central alpha-helical rod domain of lamin A/C with a high propensity to form coiled-coil dimers. The patient's cardiac evaluations that followed the genetic diagnosis revealed cardiac rhythm disturbances which were promptly treated pharmacologically.

Conclusions: This report supports the idea that there are "atypical forms" of FPLD2 with cardiomyopathy, especially when a pathogenic variant affects the lamin A/C head or alpha-helical rod domain. It also highlights how increased understanding of the genotype-phenotype correlation could help clinicians to schedule personalized monitoring of the lipodystrophic patient, in order to prevent uncommon but possible devastating manifestations, including arrhythmias and sudden death.

Keywords: LMNA gene; cardiomyopathy; laminopathy; lipodystrophy; rod domain.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Genetic Association Studies*
  • Humans
  • Lamin Type A / genetics*
  • Lamins / genetics*
  • Lipodystrophy, Familial Partial / genetics
  • Lipodystrophy, Familial Partial / pathology*
  • Mutation, Missense*
  • Prognosis

Substances

  • LMNA protein, human
  • Lamin Type A
  • Lamins
  • lamin C protein, human